Current research status of HLA in immune-related diseases
- PMID: 33657268
- PMCID: PMC8127548
- DOI: 10.1002/iid3.416
Current research status of HLA in immune-related diseases
Abstract
Human leukocyte antigen (HLA), also known as human major histocompatibility complex (MHC), is encoded by the HLA gene complex, and is currently known to have the highest gene density and the most polymorphisms among human chromosomal areas. HLA is divided into class I antigens, class II antigens, and class III antigens according to distribution and function. Classical HLA class I antigens include HLA-A, HLA-B, and HLA-C; HLA class II antigens include HLA-DP, HLA-DQ, and HLA-DR; nonclassical HLA class I and II molecules include HLA-F, E, H, X, DN, DO, and DM; and others, such as complement, are class III antigens. HLA is closely related to the body's immune response, regulation, and surveillance and is of great significance in the study of autoimmune diseases, tumor immunity, organ transplantation, and reproductive immunity. HLA is an important research topic that bridges immunology and clinical diseases. With the development of research methods and technologies, there will be more discoveries and broader prospects.
Keywords: HLA; MHC; immune-related diseases.
© 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Similar articles
-
Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex.Tissue Antigens. 1996 Aug;48(2):87-92. doi: 10.1111/j.1399-0039.1996.tb02612.x. Tissue Antigens. 1996. PMID: 8883297
-
Molecular biology of the HLA class I and class II genes.Mol Biol Med. 1986 Feb;3(1):1-11. Mol Biol Med. 1986. PMID: 3083191 Review.
-
Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order.Hum Immunol. 1986 Jun;16(2):205-19. doi: 10.1016/0198-8859(86)90049-2. Hum Immunol. 1986. PMID: 3459724
-
HLA class II antigen expression in human papillomavirus-associated cervical cancer.Cancer Res. 1992 Jul 15;52(14):4009-16. Cancer Res. 1992. PMID: 1377602
-
DNA polymorphism of HLA class I and class II regions.Immunol Rev. 1985 Jul;85:87-105. doi: 10.1111/j.1600-065x.1985.tb01131.x. Immunol Rev. 1985. PMID: 2412950 Review. No abstract available.
Cited by
-
HLA Polymorphisms and Clinical Manifestations in IgA Vasculitis.Int J Mol Sci. 2024 Jan 10;25(2):882. doi: 10.3390/ijms25020882. Int J Mol Sci. 2024. PMID: 38255953 Free PMC article.
-
Human leukocyte antigen and tumor immunotherapy (Review).Int J Oncol. 2023 Jun;62(6):68. doi: 10.3892/ijo.2023.5516. Epub 2023 Apr 28. Int J Oncol. 2023. PMID: 37114561 Free PMC article. Review.
-
Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells.Int J Mol Sci. 2021 May 26;22(11):5665. doi: 10.3390/ijms22115665. Int J Mol Sci. 2021. PMID: 34073480 Free PMC article.
-
Comprehensive Profiling of Computational Techniques for Sequencing-Based HLA Immune Signatures Extraction.HLA. 2025 Feb;105(2):e70049. doi: 10.1111/tan.70049. HLA. 2025. PMID: 39957309
-
Complex genetic variation in nearly complete human genomes.bioRxiv [Preprint]. 2024 Sep 25:2024.09.24.614721. doi: 10.1101/2024.09.24.614721. bioRxiv. 2024. Update in: Nature. 2025 Aug;644(8076):430-441. doi: 10.1038/s41586-025-09140-6. PMID: 39372794 Free PMC article. Updated. Preprint.
References
-
- Busch R, Kollnberger S, Mellins ED. HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications. Nat Rev Rheumatol. 2019;15(6):364‐381. - PubMed
-
- Katagiri T, Sato‐Otsubo A, Kashiwase K, et al. Marrow donor, frequent loss of HLA alleles associated with copy number‐neutral 6pLOH in acquired aplastic anemia. Blood. 2011;118(25):6601‐6609. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials